Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Yap

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|July 18, 2020
A Platform Incorporating Trimeric Antigens into Self-Assembling Nanoparticles Reveals SARS-CoV-2-Spike Nanoparticles to Elicit Substantially Higher Neutralizing Responses than Spike AloneBaoshan Zhang, Cara W Chao, Yaroslav Tsybovsky, et al.
The Oncologist|April 24, 2025
Barriers to publishing early phase clinical trials: the oncologists' perspectiveMerel J J Lucassen, Pedro Bergmann, Olga Husson, et al.
Nature Communications|August 1, 2025
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodiesJulia Lederhofer, Andrew J Borst, Lam Nguyen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 18, 2023
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomesHynek Mergental, Richard W Laing, Amanda J Kirkham, et al.
Scientific Reports|October 24, 2020
A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike aloneBaoshan Zhang, Cara W Chao, Yaroslav Tsybovsky, et al.
Vaccines|January 26, 2021
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing ResponsesYongping Yang, Wei Shi, Olubukola M Abiona, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Structural Convergence and Water-Mediated Substrate Mimicry Enable Broad Neuraminidase Inhibition by Human AntibodiesJulia Lederhofer, Andrew J Borst, Lam Nguyen, et al.
European Urology Oncology|May 1, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate CancerMaría Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, et al.
Nature Communications|June 18, 2020
Transplantation of discarded livers following viability testing with normothermic machine perfusionHynek Mergental, Richard W Laing, Amanda J Kirkham, et al.
Journal for Immunotherapy of Cancer|June 18, 2022
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumorsDionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|July 18, 2020
A Platform Incorporating Trimeric Antigens into Self-Assembling Nanoparticles Reveals SARS-CoV-2-Spike Nanoparticles to Elicit Substantially Higher Neutralizing Responses than Spike AloneBaoshan Zhang, Cara W Chao, Yaroslav Tsybovsky, et al.
The Oncologist|April 24, 2025
Barriers to publishing early phase clinical trials: the oncologists' perspectiveMerel J J Lucassen, Pedro Bergmann, Olga Husson, et al.
Nature Communications|August 1, 2025
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodiesJulia Lederhofer, Andrew J Borst, Lam Nguyen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 18, 2023
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomesHynek Mergental, Richard W Laing, Amanda J Kirkham, et al.
Scientific Reports|October 24, 2020
A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike aloneBaoshan Zhang, Cara W Chao, Yaroslav Tsybovsky, et al.
Vaccines|January 26, 2021
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing ResponsesYongping Yang, Wei Shi, Olubukola M Abiona, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Structural Convergence and Water-Mediated Substrate Mimicry Enable Broad Neuraminidase Inhibition by Human AntibodiesJulia Lederhofer, Andrew J Borst, Lam Nguyen, et al.
European Urology Oncology|May 1, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate CancerMaría Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, et al.
Nature Communications|June 18, 2020
Transplantation of discarded livers following viability testing with normothermic machine perfusionHynek Mergental, Richard W Laing, Amanda J Kirkham, et al.
Journal for Immunotherapy of Cancer|June 18, 2022
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumorsDionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal, et al.
Pageof 9